Novartis Gets CDSCO Panel nod to study antimalarial drug KLU156 with Coartem Dr. Divya Colin14 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
ResMed recalls CPAP Masks with magnets, USFDA terms it most serious Ruchika Sharma13 Jan 2024 11:02 AM ISTUS: ResMed Ltd. has recalling all their Continuous Positive Airway Pressure (CPAP) masks with magnets due to possible magnetic interference with...
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III CT of Triptorelin to treat chronic pain linked to endometriosis: CDSCO Panel Tells Dr Reddy's Lab Dr. Divya Colin11 Jan 2024 6:00 PM ISTNew Delhi: Citing that the pharmaceutical giant Dr. Reddy's Laboratories has not supplied data on the Indian population for the management and relief...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
Good Manufacturing Practices: Govt releases Schedule M guidelines, calls for stricter quality control, recall measures Ruchika Sharma9 Jan 2024 2:30 PM ISTSome of the major changes which will happen with introduction of revised Schedule M to support upgradation of the units are introduction of...
Justify Durvalumab dose: CDSCO Panel Tells AstraZeneca on Study of Dato-DXd and Durvalumab Dr. Divya Colin8 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the drug major AstraZeneca's Phase III clinical trial protocol of the anti-cancer drug of Dato-DXd and Durvualumab, the Subject...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Giredestrant for Breast Cancer Dr. Divya Colin7 Jan 2024 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA fixes Retail Prices of 19 Formulations, Details Susmita Roy6 Jan 2024 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers, Government...
AstraZeneca Gets CDSCO Panel Nod to Study anti-cancer drug Dato-DXd and Durvalumab Dr. Divya Colin5 Jan 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit Separate Toxicity Data on Indian Subject: CDSCO Panel Tells GSK on BelantamabMafodotin study Dr. Divya Colin4 Jan 2024 6:00 PM ISTNew Delhi: Considering the serious adverse events in the study data (phase-I & II) of Belantamab Mafodotin (GSK2857916) for Injection 100mg...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin3 Jan 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
